Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients

• Published in: Antimicrobial agents and chemotherapy Vol. 61; no. 12
• Main Authors: Medellín-Garibay, Susanna Edith, Romano-Moreno, Silvia, Tejedor-Prado, Pilar, Rubio-Álvaro, Noelia, Rueda-Naharro, Aida, Blasco-Navalpotro, Miguel Angel, García, Benito, Barcia, Emilia
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 01.12.2017
• Subjects: Anti-Bacterial Agents; Clinical Therapeutics; Creatinine; Critical Illness; Respiration, Artificial; Vancomycin; vancomycin; dosing recommendations; intensive care; mechanical ventilation; stochastic simulations; population pharmacokinetics
• ISSN: 0066-4804; 1098-6596
• DOI: 10.1128/AAC.01249-17

Pathophysiological changes involved in drug disposition in critically ill patients should be considered in order to optimize the dosing of vancomycin administered by continuous infusion, and certain strategies must be applied to reach therapeutic targets on the first day of treatment. The aim of this study was to develop a population pharmacokinetic model of vancomycin to determine clinical covariates, including mechanical ventilation, that influence the wide variability of this antimicrobial. Plasma vancomycin concentrations from 54 critically ill patients were analyzed simultaneously by a population pharmacokinetic approach. A nomogram for dosing recommendations was developed and was internally evaluated through stochastic simulations. The plasma vancomycin concentration-versus-time data were best described by a one-compartment open model with exponential interindividual variability associated with vancomycin clearance and the volume of distribution. Residual error followed a homoscedastic trend. Creatinine clearance and body weight significantly dropped the objective function value, showing their influence on vancomycin clearance and the volume of distribution, respectively. Characterization based on the presence of mechanical ventilation demonstrated a 20% decrease in vancomycin clearance. External validation ( = 18) was performed to evaluate the predictive ability of the model; median bias and precision values were 0.7 mg/liter (95% confidence interval [CI], -0.4, 1.7) and 5.9 mg/liter (95% CI, 5.4, 6.4), respectively. A population pharmacokinetic model was developed for the administration of vancomycin by continuous infusion to critically ill patients, demonstrating the influence of creatinine clearance and mechanical ventilation on vancomycin clearance, as well as the implications for targeting dosing rates to reach the therapeutic range (20 to 30 mg/liter).